Translating epigenetic modulation of oncogenic pathways into first-in-class small molecule therapeutics
Headquarters | Cambridge, MA |
Website | https://www.k36tx.com/ |
Pipeline Status | Preclinical |
K36 Therapeutics |
Translating epigenetic modulation of oncogenic pathways into first-in-class small molecule therapeutics
Headquarters | Cambridge, MA |
Website | https://www.k36tx.com/ |
Pipeline Status | Preclinical |
K36 Therapeutics |